Dashboard
Manage Tickers

EPZM Epizyme, Inc.

Nasdaq www.epizyme.com


$ -0.02 (-1.34 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.65 $ -4.35 (-0.69 %)
DIA $ 475.54 $ -0.31 (-0.07 %)
SPY $ 682.42 $ -2.65 (-0.39 %)
TLT $ 90.31 $ -0.25 (-0.28 %)
GLD $ 368.26 $ -2.17 (-0.59 %)
$ 1.47
-- x --
-- x --
-- - --
$ 0.41 - $ 5.80
22,276,017
na
245.48M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2022 06-30-2022 10-Q
2 05-10-2022 03-31-2022 10-Q
3 03-01-2022 12-31-2021 10-K
4 11-09-2021 09-30-2021 10-Q
5 08-09-2021 06-30-2021 10-Q
6 05-06-2021 03-31-2021 10-Q
7 02-23-2021 12-31-2020 10-K
8 11-06-2020 09-30-2020 10-Q
9 08-04-2020 06-30-2020 10-Q
10 05-04-2020 03-31-2020 10-Q
11 02-27-2020 12-31-2019 10-K
12 10-31-2019 09-30-2019 10-Q
13 08-09-2019 06-30-2019 10-Q
14 05-06-2019 03-31-2019 10-Q
15 02-26-2019 12-31-2018 10-K
16 11-02-2018 09-30-2018 10-Q
17 08-02-2018 06-30-2018 10-Q
18 05-08-2018 03-31-2018 10-Q
19 03-13-2018 12-31-2017 10-K
20 11-01-2017 09-30-2017 10-Q
21 08-07-2017 06-30-2017 10-Q
22 05-08-2017 03-31-2017 10-Q
23 03-13-2017 12-31-2016 10-K
24 11-03-2016 09-30-2016 10-Q
25 08-08-2016 06-30-2016 10-Q
26 05-09-2016 03-31-2016 10-Q
27 03-09-2016 12-31-2015 10-K
28 11-09-2015 09-30-2015 10-Q
29 08-06-2015 06-30-2015 10-Q
30 04-28-2015 03-31-2015 10-Q
31 03-12-2015 12-31-2014 10-K
32 11-06-2014 09-30-2014 10-Q
33 08-13-2014 06-30-2014 10-Q
34 05-14-2014 03-31-2014 10-Q
35 02-28-2014 12-31-2013 10-K
36 10-23-2013 09-30-2013 10-Q
37 08-01-2013 06-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

looking-into-epizymes-return-on-capital-employed
Looking Into Epizyme's Return On Capital E...
09/02/2022 14:27:31

According to Benzinga Pro data, during Q2, Epizyme (NASDAQ:EPZM) posted sales of $27.53 million. Earnings were up 35.6%, but Ep...

epizyme-q2-earnings-insights
Epizyme: Q2 Earnings Insights
08/09/2022 12:56:57

  Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors ne...

epizyme-q2-eps-021-up-from-063-yoy
Epizyme Q2 EPS $(0.21) Up From $(0.63) YoY
08/09/2022 11:28:48

Epizyme (NASDAQ:EPZM) reported quarterly losses of $(0.21) per share. This is a 66.67 percent increase over losses of $(0.63) p...

benzingas-top-ratings-upgrades-downgrades-for-june-28-2022
Benzinga's Top Ratings Upgrades, Downgrade...
06/28/2022 14:25:33

Upgrades

epizyme-granted-us-patent-11370781-combination-therapy-for-treating-cancer
Epizyme Granted U.S. Patent #11,370,781 Co...
06/28/2022 10:44:22

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5571&...

cowen--co-downgrades-epizyme-to-market-perform-announces-15-price-target
Cowen & Co. Downgrades Epizyme to Market P...
06/28/2022 10:08:53

Cowen & Co. analyst Joseph Thome downgrades Epizyme (NASDAQ:EPZM) from Outperform to Market Perform and announces $1.5 p...

this-healthcare-stock-jumps-around-188-heres-83-biggest-movers-from-yesterday
This Healthcare Stock Jumps Around 188%, H...
06/28/2022 08:23:47

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court over...

why-is-neurosense-therapeutics-surging-by-70-46-stocks-moving-in-mondays-mid-day-session
Why Is NeuroSense Therapeutics Surging By ...
06/27/2022 16:26:34

 Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

the-daily-biotech-pulse-chmp-backs-astrazenecas-breast-cancer-therapies-ipsen-buys-epizyme-fda-holds-for-nuvation-bio-astellas-studies
The Daily Biotech Pulse: CHMP Backs AstraZ...
06/27/2022 14:50:53

Here's a roundup of top developments in the biotech space over the last 24 hours:

benzingas-top-ratings-upgrades-downgrades-for-june-27-2022
Benzinga's Top Ratings Upgrades, Downgrade...
06/27/2022 14:06:43

Upgrades

why-epizyme-shares-are-soaring-today
Why Epizyme Shares Are Soaring Today
06/27/2022 13:46:42

Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement ...

wedbush-downgrades-epizyme-to-neutral
Wedbush Downgrades Epizyme to Neutral
06/27/2022 13:00:12

Wedbush analyst David Nierengarten downgrades Epizyme (NASDAQ:EPZM) from Outperform to Neutral.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/27/2022 12:40:39

 

ipsen-scoops-up-blood-cancer-focused-epizyme---read-why
Ipsen Scoops Up Blood Cancer-Focused Epizy...
06/27/2022 10:45:30

Ipsen SA (OTC: IPSEY) has 

epizyme--20-stocks-moving-in-mondays-pre-market-session
Epizyme + 20 Stocks Moving In Monday's Pre...
06/27/2022 10:31:39

Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Fr...

Core News & Articles
Ipsen to Acquire Epizyme for $1.45/Share i...
06/27/2022 09:15:59

Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today announced that they have entered into a definitive merger ag...

76-biggest-movers-from-yesterday-ocean-bio-chem-athira-pharma-and-more
76 Biggest Movers From Yesterday: Ocean Bi...
06/23/2022 08:25:36

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announc...

40-stocks-moving-in-wednesdays-mid-day-session
40 Stocks Moving In Wednesday's Mid-Day Se...
06/22/2022 16:17:03

 Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired b...

20-stocks-moving-in-tuesdays-pre-market-session
20 Stocks Moving in Tuesday's Pre-Market S...
06/14/2022 09:54:43

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 48.5% to $2.57 in pre-market trading after the company rea...

93-biggest-movers-from-yesterday
93 Biggest Movers From Yesterday
06/14/2022 07:58:38

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company an...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION